"Pioneering Clinical Trials: Bringing Hope to Communities at Risk"

Clinical Trial Phases

Equivac’s clinical trials are structured in multiple phases, each designed to rigorously evaluate the vaccine’s safety, efficacy, and immunogenicity

Phase I: Safety and dosage evaluation in a small group of healthy adults.

Phase II: Immunogenicity and preliminary efficacy assessment in a larger population.

Phase III: Large-scale efficacy and safety evaluation involving thousands of participants across multiple locations.

Phase IV: Post-marketing surveillance to monitor long-term safety and effectiveness.

“Each phase brings us closer to a vaccine that can change lives.”